[HTML][HTML] Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II
M Fathi-Kazerooni, S Fattah-Ghazi, M Darzi… - Stem Cell Research & …, 2022 - Springer
Abstract Background Cell-free Mesenchymal stromal cells (MSCs) have been considered
due to their capacity to modulate the immune system and suppress cytokine storms caused …
due to their capacity to modulate the immune system and suppress cytokine storms caused …
Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II.
M Fathi-Kazerooni, S Fattah-Ghazi, M Darzi… - Stem Cell Research & …, 2022 - europepmc.org
Background Cell-free Mesenchymal stromal cells (MSCs) have been considered due to their
capacity to modulate the immune system and suppress cytokine storms caused by SARS …
capacity to modulate the immune system and suppress cytokine storms caused by SARS …
[PDF][PDF] Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID‑19 patients: clinical trial phase I & II
M Fathi‑Kazerooni, S Fattah‑Ghazi… - Stem Cell Research …, 2022 - scienceopen.com
Abstract Background: Cell‑free Mesenchymal stromal cells (MSCs) have been considered
due to their capacity to modulate the immune system and suppress cytokine storms caused …
due to their capacity to modulate the immune system and suppress cytokine storms caused …
Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II
M Fathi-Kazerooni, S Fattah-Ghazi, M Darzi… - 2022 - pubmed.ncbi.nlm.nih.gov
Background Cell-free Mesenchymal stromal cells (MSCs) have been considered due to their
capacity to modulate the immune system and suppress cytokine storms caused by SARS …
capacity to modulate the immune system and suppress cytokine storms caused by SARS …
Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II.
M Fathi-Kazerooni, S Fattah-Ghazi, M Darzi… - Stem Cell Research & …, 2022 - go.gale.com
Background Cell-free Mesenchymal stromal cells (MSCs) have been considered due to their
capacity to modulate the immune system and suppress cytokine storms caused by SARS …
capacity to modulate the immune system and suppress cytokine storms caused by SARS …
[HTML][HTML] Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II
M Fathi-Kazerooni, S Fattah-Ghazi… - Stem Cell Research & …, 2022 - ncbi.nlm.nih.gov
Background Cell-free Mesenchymal stromal cells (MSCs) have been considered due to their
capacity to modulate the immune system and suppress cytokine storms caused by SARS …
capacity to modulate the immune system and suppress cytokine storms caused by SARS …
Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II.
M Fathi-Kazerooni, S Fattah-Ghazi… - Stem Cell Research …, 2022 - search.ebscohost.com
Abstract Background: Cell-free Mesenchymal stromal cells (MSCs) have been considered
due to their capacity to modulate the immune system and suppress cytokine storms caused …
due to their capacity to modulate the immune system and suppress cytokine storms caused …
Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II
M Fathi-Kazerooni, S Fattah-Ghazi, M Darzi… - 2022 - agris.fao.org
Abstract Background Cell-free Mesenchymal stromal cells (MSCs) have been considered
due to their capacity to modulate the immune system and suppress cytokine storms caused …
due to their capacity to modulate the immune system and suppress cytokine storms caused …
[HTML][HTML] Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II
M Fathi-Kazerooni… - … Cell Research & …, 2022 - stemcellres.biomedcentral.com
Cell-free Mesenchymal stromal cells (MSCs) have been considered due to their capacity to
modulate the immune system and suppress cytokine storms caused by SARS-CoV-2. This …
modulate the immune system and suppress cytokine storms caused by SARS-CoV-2. This …
[PDF][PDF] Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID‑19 patients: clinical trial phase I & II
M Fathi‑Kazerooni… - … Cell Research & …, 2022 - stemcellres.biomedcentral.com
Abstract Background: Cell‑free Mesenchymal stromal cells (MSCs) have been considered
due to their capacity to modulate the immune system and suppress cytokine storms caused …
due to their capacity to modulate the immune system and suppress cytokine storms caused …